KLRS

KALARIS THERAPEUTICS INC

KLRS·482929106·US·Common Stock·Healthcare - Biotechnology-Activist

KLRS (KALARIS THERAPEUTICS INC) is held by 33 institutional investors as of Q2 2026. Largest holders: RTW INVESTMENTS, LP ($5.3M), Alyeska Investment Group, L.P. ($2.3M), VANGUARD CAPITAL MANAGEMENT LLC ($1.6M). Net institutional sentiment: Mixed.

33
Holders
$15M
Total Value
59% (29)
Consensus
17 buying - 12 selling
13F: Insider & Congress: Updated regularly
KLRS

Smart Money Verdict

View all
Loading verdict
Held by 33 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders Mar 23, 2026 · Activists May 22, 2026 · Congress none

ActivistSBSamsara BioCapital, L.P.44.8%May 22, 2026
InsiderHRHagen Brett RSell $13KMar 20, 2026
ActivistRTW Investments, LPRTW Investments, LP5.7%Feb 17, 2026
Checking access…

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Unchanged
1.3M$5.3M0.0%-51.31%
0
Unchanged
572,687$2.3M0.0%-53.03%
0
Increased
398,712(+56.1%)$1.6M0.0%-45.57%
25
Increased
262,131(+4138.9%)$1.1M0.0%-2.46%
41
Increased
149,351(+125.8%)$607,8590.0%-0.84%
39
Increased
139,201(+105.1%)$566,5490.0%-34.11%
39
Increased
114,037(+30.3%)$464,2870.0%-39.80%
21
Unchanged
100,000$407,0000.0%-35.75%
0
Decreased
97,164(-18.3%)$395,4570.0%-52.81%
0
New
95,772$389,7920.0%+0.25%
36
Increased
72,326(+88.6%)$294,3670.0%-29.79%
25
Increased
66,179(+80.2%)$269,3490.0%-42.03%
36
Increased
54,442(+51.0%)$221,5800.0%-31.35%
22
Decreased
38,775(-2.5%)$157,8140.0%-32.28%
0
Increased
30,007(+119.8%)$122,1280.0%-33.69%
36
New
29,737$121,0300.0%+0.25%
30
Unchanged
26,510$107,8960.0%-46.32%
0
Increased
25,839(+78.8%)$105,1650.0%-37.35%
23
Decreased
23,847(-22.2%)$97,0570.0%-51.88%
0
New
16,527$67,2650.0%+0.25%
29

Showing 1-20 of 37

1 / 2
KLRSKLRSKALARIS THERAPEUTICS INC

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used